4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide

C18H25N3O3 — CID 48581633

IUPAC4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide
SMILESO=C(NCCN1CCOCC1)c1ccc(NC(=O)C2CCC2)cc1
InChIInChI=1S/C18H25N3O3/c22-17(19-8-9-21-10-12-24-13-11-21)15-4-6-16(7-5-15)20-18(23)14-2-1-3-14/h4-7,14H,1-3,8-13H2,(H,19,22)(H,20,23)
InChIKeyWDFHKVBQQOTPCT-UHFFFAOYSA-N
MW331.42 g/mol
LogP1.49
Rot. Bonds6

About 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide

4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide (PubChem CID 48581633) has the molecular formula C18H25N3O3 and a molecular weight of 331.42 g/mol. Its IUPAC name is 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide.

Molecular Properties

Compound Name4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide
PubChem CID48581633
Molecular FormulaC18H25N3O3
Molecular Weight331.42 g/mol
Exact Mass331.19
IUPAC Name4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide
SMILESO=C(NCCN1CCOCC1)c1ccc(NC(=O)C2CCC2)cc1
InChIInChI=1S/C18H25N3O3/c22-17(19-8-9-21-10-12-24-13-11-21)15-4-6-16(7-5-15)20-18(23)14-2-1-3-14/h4-7,14H,1-3,8-13H2,(H,19,22)(H,20,23)
InChIKeyWDFHKVBQQOTPCT-UHFFFAOYSA-N
XLogP1.49
TPSA70.67 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500331.42
LogP ≤ 51.49
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[(3-aminocyclohexanecarbonyl)amino]-N-(2-morpholin-4-ylethyl)benzamide
CID 119865091
(2S,4S)-2-methyl-N-[4-(2-morpholin-4-ylethylcarbamoyl)phenyl]piperidine-4-carboxamide
CID 120645418
(2S,5R)-5-(aminomethyl)-N-[4-(2-morpholin-4-ylethylcarbamoyl)phenyl]oxolane-2-carboxamide
CID 120799120
4-[(4-chlorobenzoyl)amino]-N-(2-morpholin-4-ylethyl)benzamide
CID 48581606
N-[4-(2-pyrrolidin-1-ylethylcarbamoyl)phenyl]piperidine-3-carboxamide;dihydrochloride
CID 119885582
4-(ethylamino)-N-(2-morpholin-4-ylethyl)benzamide
CID 62166054
1-[4-(cyclopropanecarbonylamino)phenyl]-N-(2-morpholin-4-ylethyl)cyclohexane-1-carboxamide
CID 20972789
4-[6-(cyclobutanecarbonylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-N-(2-piperidin-1-ylethyl)benzamide
CID 53159894
4-methyl-N-(2-morpholin-4-ylethyl)benzamide
CID 803484
N-[4-[2-(4-methylpiperidin-1-yl)ethylcarbamoyl]phenyl]oxolane-2-carboxamide
CID 3238521
(2R)-N-[4-(2-pyrrolidin-1-ylethylcarbamoyl)phenyl]piperidine-2-carboxamide
CID 119885587
3-fluoro-N-[4-(2-morpholin-4-ylethylcarbamoyl)phenyl]benzamide
CID 48581644

Frequently Asked Questions

What is the IUPAC name of 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide?
The IUPAC name of 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide (CID 48581633) is 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide.
What is the SMILES notation for 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide?
The canonical SMILES for 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide is O=C(NCCN1CCOCC1)c1ccc(NC(=O)C2CCC2)cc1.
What is the InChIKey of 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide?
The InChIKey is WDFHKVBQQOTPCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H25N3O3/c22-17(19-8-9-21-10-12-24-13-11-21)15-4-6-16(7-5-15)20-18(23)14-2-1-3-14/h4-7,14H,1-3,8-13H2,(H,19,22)(H,20,23).
What are the key properties of 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide?
4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide has a molecular weight of 331.42 g/mol, XLogP of 1.49, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(cyclobutanecarbonylamino)-N-(2-morpholin-4-ylethyl)benzamide is sourced from PubChem (CID 48581633), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).